
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.360 | 0.480 | 0.120 |
Shares | 99.640 | 99.640 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.088 | 17.057 |
Price to Book | 4.779 | 2.603 |
Price to Sales | 3.205 | 1.909 |
Price to Cash Flow | 15.787 | 11.328 |
Dividend Yield | 0.514 | 2.184 |
5 Years Earnings Growth | 11.451 | 12.320 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.410 | 20.905 |
Industrials | 31.130 | 16.888 |
Healthcare | 24.160 | 13.453 |
Consumer Cyclical | 3.560 | 10.831 |
Financial Services | 1.750 | 13.218 |
Number of long holdings: 71
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Intuitive Surgical | US46120E6023 | 2.92 | 482.42 | +0.22% | |
Cyberark Software | IL0011334468 | 2.91 | 325.17 | -1.85% | |
Fair Isaac | US3032501047 | 2.87 | 1,908.69 | +0.47% | |
Cloudflare | US18915M1071 | 2.83 | 107.90 | -1.51% | |
Verisk | US92345Y1064 | 2.82 | 293.03 | +0.27% | |
Fortinet | US34959E1091 | 2.73 | 96.13 | +0.06% | |
Halma | GB0004052071 | 2.65 | 2,656.0 | -0.38% | |
CrowdStrike Holdings | US22788C1053 | 2.62 | 375.62 | -1.11% | |
Thermo Fisher Scientific | US8835561023 | 2.62 | 427.50 | -2.13% | |
Experian | GB00B19NLV48 | 2.59 | 3,445.0 | -0.52% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Security Equity Fund IB USD | 2.16B | 7.97 | 9.43 | 11.96 | ||
Global Security Equity Fund B USD | 2.16B | 5.00 | 7.33 | 10.05 | ||
CS Lux Digital Health Equity IB | 723.36M | -5.86 | -12.94 | - | ||
LU1683287707 | 723.36M | -5.82 | -12.90 | - | ||
LU1683285164 | 723.36M | -6.52 | -13.54 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review